about
Emerging roles for the non-canonical IKKs in cancerPrecursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic ApproachesThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsNF-κB in cellular senescence and cancer treatmentDynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentAn immunologic portrait of cancerLoss of hairless confers susceptibility to UVB-induced tumorigenesis via disruption of NF-kappaB signalingThe inflammasome: an emerging therapeutic oncotarget for cancer preventionGemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cellsThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisSustained proliferation in cancer: Mechanisms and novel therapeutic targetsTissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cellsEndocytosis-independent function of clathrin heavy chain in the control of basal NF-κB activationOverexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progressionAnti-cancer activity of a novel small molecule compound that simultaneously activates p53 and inhibits NF-κB signalingFatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growthMCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κBChronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismCrotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathwayOral epithelial stem cells - implications in normal development and cancer metastasis.Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and upregulation of IL-1Ra in melanoma modelp66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition.Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-кB mediated matrix metalloproteinase-1 gene regulation.Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFκB binding to ST8SIA1 promoter.Role of Notch and its oncogenic signaling crosstalk in breast cancer.miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.IκΒα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention.T cell-NF-κB activation is required for tumor control in vivoNF-κB addiction and its role in cancer: 'one size does not fit all'.Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer.Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-κB-p53-caspase-3 pathwayDownregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo.Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation.PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
P2860
Q24305225-A36FAAF8-5234-4978-932D-6465C32357BCQ24633674-65B7D8CF-0368-4E7C-84AB-21C646639F20Q26752576-5BD31808-FF42-4953-8B45-7FF01DC5A027Q26800055-53A4CC3A-7F9E-49FD-A35F-AB3579B76DDEQ26861403-73F46079-1049-4B89-8E51-8E8F93E82101Q27007045-CD0AE3A4-AA66-4D06-A2B5-44E20DAF1EE0Q27025321-C093D391-11D8-480E-AD36-661E569AFFC7Q27028000-ED5E6D57-1F6D-42A8-BF81-F348A02F3E98Q27300739-0BA903BF-E632-476F-B20F-6F5564C18AFBQ28076914-EFA1EEBB-2FFA-4519-A864-067C550668F6Q28297927-28BCAAE4-5C09-443E-885C-26B109717C7DQ28388257-D7B510CE-3AF7-4F9F-BC59-7BF59E17526BQ28396388-3AA53F58-1E8F-4611-A934-C82379BF1DFAQ28475746-E6609235-4523-44F7-924D-FBA88A732EB4Q28477279-2BDE0256-608A-4250-B820-22EA2531A3B4Q28483701-2C024928-3C5E-4E59-A73E-470E92929145Q28483751-976FE89C-41A1-439D-BA49-656898C5E598Q33911239-E76BA464-3342-420E-84B0-10130A7D919FQ34038263-D12D0D67-B3C9-4BFF-8070-8F51CDC24D6CQ34079481-F985D66B-3983-4AB1-8ECC-247EDAF2CC64Q34094406-C6C67F8B-BD89-463F-A715-CEBCAEE112BCQ34147649-1D79BC5D-2702-4A34-B640-658841EDC247Q34148357-612BA4E2-4624-482B-9DCB-66E746563024Q34261494-FF1615F7-F613-43EE-8B6B-477CE8E92D9DQ34298024-CAFD3FC3-2889-4B4C-9BFB-44E0518F932CQ34305025-AD299BA5-C1C7-4D08-98E5-6E8D541118CEQ34468776-637C66C7-30E3-47E3-A831-7F08C80CE641Q34489967-906C33E7-1C7B-423C-A362-0A25340CFC71Q34693290-F4E97B73-6D13-42D4-B07A-62B513254F40Q34697373-66C939C3-1170-44DC-B042-67DFAFF0BB64Q34787462-8EE6BBD0-5D48-4844-9B91-DB6FFB6328DEQ34802998-AA095582-FB01-46B3-86D1-87DFE297DF00Q34806907-DC8E7E62-BB20-4811-A49D-9B09D2EDFACBQ35021163-AA499C78-62BF-404B-9A4F-211862A0CA95Q35120893-9EB0A41C-BC65-410E-84CC-549D9E438CCEQ35125181-08FC8E3F-2810-4552-A2AE-389D4E799E03Q35159571-33F83589-A624-4156-9F2A-102C61C40675Q35227386-E5059E34-2BAE-4F38-982E-2A53F33E3813Q35252803-700BB3F1-F1CC-49C5-A21C-193B5E0A7A44Q35410911-FDA91EF5-F154-40D2-A555-39AB4A4D7D69
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
NF-kappaB and cancer: how intimate is this relationship
@ast
NF-kappaB and cancer: how intimate is this relationship
@en
type
label
NF-kappaB and cancer: how intimate is this relationship
@ast
NF-kappaB and cancer: how intimate is this relationship
@en
prefLabel
NF-kappaB and cancer: how intimate is this relationship
@ast
NF-kappaB and cancer: how intimate is this relationship
@en
P2093
P2860
P1476
NF-kappaB and cancer: how intimate is this relationship
@en
P2093
Bharat B Aggarwal
Jayaraj Ravindran
Sahdeo Prasad
P2860
P2888
P356
10.1007/S11010-009-0267-2
P577
2009-10-08T00:00:00Z